Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NIH Translational Science Center Defended On Capitol Hill

This article was originally published in The Gray Sheet

Executive Summary

NIH Director Francis Collins March 20 defends his newly formed National Center for Advancing Translational Science, which is aimed at turning new diagnostic and therapeutic discoveries into viable products, before a highly suspicious House Appropriations Labor-HHS Subcommittee.

You may also be interested in...

NIH Sequester: Grants Down, But SBIR Program Less Impacted

Each institute within NIH has taken a slightly different approach to responding to the sequestration cuts, and, generally, the Small Business Innovation Research and Small Business Technology Transfer grant programs are subject to less significant reductions than traditional grants.

Senate Panel Supports $56 Million Boost For NIH Translational Science Center

The National Center for Advancing Translational Sciences would get a sizable chunk of the funding increase approved for NIH by the Senate Appropriations Committee but support for increasing its budget is not universal.

Health Care Reform Spending Much Lower Than Originally Estimated, Sebelius Testifies

HHS Secretary Kathleen Sebelius defends fiscal 2013 budget, telling a House subcommittee that implementing the Affordable Care Act has so far cost only a fraction of the $1 billion per year originally forecast by the Congressional Budget Office.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts